Anti-inflammatory pathway overlap each compound has reported anti-inflammatory effects through different pathways in preclinical models
Remove mask and gently pat remaining essence into skin until fully absorbed
Building awareness around these behaviors helps patients understand why they struggle and how medication can supportnot replacebehavioral change
At Self London, our role is to ensure that weight loss not only transforms health but supports confidence in face and body too
Results Study Participants As shown in Figure 1, out of the 101 study participants, 6 were using Dulaglutide (Trulicity), 13 were using Tirzepatide (Mounjaro), 14 were using Semaglutide (WeGovy), 17 were using Liraglutide (Saxenda), 48 were using Semaglutide (Ozempic), and 3 did not report which medication they were using
Patients following microdose pathways often experience less dramatic side effects during weeks one through four, creating space for dietary habit changes without overwhelming gastrointestinal symptoms
